#Switzerland #Basel #Jungbunzlauer #Tricalcium Citrate #Direct Compression

Jungbunzlauer's New Breakthrough in Tableting Technology

Jungbunzlauer, a global leader in premium sustainable ingredients, along with Professor Karl Wagner from the University of Bonn, has announced significant developments in the use of Tricalcium Citrate (TCC TB) as an excipient for tablet manufacturing. This innovative collaboration has established TCC TB as a gold standard in the direct compression process crucial for pharmaceutical and nutraceutical applications.

The research highlights TCC TB's exceptional properties, showcasing its capacity to enhance tablet formulation's efficiency and quality. The findings emphasize that this excipient not only boasts impressive flowability but also maintains tablet strength under minimal pressure, making it particularly effective for challenging formulations that include moisture-sensitive active ingredients and herbal compounds.

Markus Gerhart, Senior Director Category Lead of Minerals Solutions at Jungbunzlauer, stated, "Our partnership with Professor Wagner underscores our commitment to rigorous science, innovation, and superior products. We are excited to present validated studies demonstrating that our TCC TB facilitates reliable performance in direct compression, aiding customers in achieving efficiency, quality, and trust in their products."

In recent years, the pharmaceutical industry has increasingly favored direct compression techniques due to their efficiency and compatibility with delicate ingredients. However, these methods require excipients that excel in flowability and compactibility. The recent studies confirm that TCC TB meets these requirements admirably, enabling robust tablet formation even in low-pressure scenarios, making it a tremendous asset for manufacturers.

The production of TCC TB involves a meticulous process of completely neutralizing citric acid with a high-purity calcium source, resulting in a product certified to be vegan, allergen-free, and GMO-free. It also adheres to USP, FCC, and EU standards, further establishing its credibility in the marketplace.

These groundbreaking insights will be presented at CPHI Global, held in Frankfurt from October 28 to 30, 2025, where attendees are encouraged to engage with Jungbunzlauer representatives to explore how TCC TB can support upcoming formulation challenges, paving the way for natural solutions in the industry.

The Importance of Sustainable Ingredients

Jungbunzlauer is dedicated to manufacturing high-quality, sustainable ingredients from natural sources, catering to various sectors, including food and beverages, nutrition, health, home care, and personal care. The company prides itself on developing naturally better ingredients that enhance daily life, serving as a reliable partner offering a diverse portfolio of texture agents, acids, sweeteners, minerals, and tailored solutions to meet the evolving needs of its clients.

Headquartered in Basel, Switzerland, Jungbunzlauer operates state-of-the-art facilities, including large-scale fermentation units in Europe and North America, servicing over 130 countries worldwide. Since its inception over 150 years ago, Jungbunzlauer has evolved into a major player with a revenue of 1.3 billion CHF, driven by nearly 1,400 dedicated employees committed to a healthier and more sustainable future. For more information about Jungbunzlauer and its innovative offerings, please visit www.jungbunzlauer.com.